Search results

• April 30 2020

  The antiviral drug remdesivir reduces the time to recovery in COVID-19 patients

  These are the first results of a global clinical trial in which the Hospital Clinic and ISGlobal participate.

  Notícias
• May 11 2020

  Coronavirus and diabetes. What do the experts recommend?

  Any infection in a person who suffers diabetes has a double risk: on the one hand, it may decompensate the diabetes itself; and on the other, any com1

  Notícias
• May 26 2020

  A new cancer immune therapy spin-off of Hospital Clínic-IDIBAPS secures a 1.5 million-euro investment from Invivo Ventures

  Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating h1

  Notícias
• May 26 2020

  Does having an autoimmune disease make you more susceptible to catching COVID-19?

  The immune system of people with diseases like lupus or rheumatoid arthritis malfunctions and attacks cells in their own bodies. This is why they are1

  Notícias
• June 3 2020

  The challenges of psychological and psychiatric care in the time of COVID-19

  Lockdown situations can lead to feelings of stress, frustration, guilt, or even anxiety in the general public. Also, people with mental disorders are1

  Notícias
• June 3 2020

  Researchers identify two marine molecules with therapy potential against Alzheimer’s disease

  Researchers of IDIBAPS have participated in an interdisciplinary research study of the UB in which there have been identified two potential candidate1

  Notícias
• June 9 2020

  People living with HIV are not more susceptible to the COVID-19 virus

  The COVID-19 pandemic has raised concerns about the risk of people with different kinds of immunosuppression developing more serious forms of the inf1

  Notícias
• June 10 2020

  A consortium of European hospitals led by Clínic IDIBAPS is launching a cellular immunotherapy project to tackle COVID-19 with the support of Cellnex Telecom

  Hospital Clínic de Barcelona-IDIBAPS and Cellnex have today signed an agreement to launch a multicentre research project that will allow better under1

  Notícias
• June 15 2020

  Returning to exercise during the COVID-19 pandemic

  The SARS-CoV2 pandemic has impacted society in very diverse ways. Many people have changed their habits due to lockdown, such as practising physical1

  Notícias
• June 23 2020

  Heart attack admissions decline during COVID-19

  It has been observed that cardiovascular disease and COVID-19 are related in various ways, one of the most dangerous of which is patients with heart1

  Notícias
• June 29 2020

  Coronavirus has a more serious impact on patients with haematological diseases

  People who have a haematological disease, such as lymphoma or leukaemia, present a state of immunosuppression caused both by the illness itself and t1

  Notícias
• July 7 2020

  How to tell the difference between allergy symptoms and COVID

  During the COVID-19 pandemic, allergists and other specialists such as pulmonologists, ENT specialists, internists and dermatologists have attended t1

  Notícias
• July 14 2020

  Thrombosis are one of the main complications associated with COVID-19

  Thrombosis, especially venous thrombosis, are one of the serious complications that can appear in patients affected by COVID-19. These complicat1

  Notícias
• July 22 2020

  Behaviours to prevent anxiety and depression during the pandemic

  The pandemic and lockdown caused by COVID-19 have increased symptoms of anxiety and depression in the population. However, according to a major surve1

  Notícias
• July 23 2020

  Treatment with tocilizumab in patients with kidney transplant reduces mortality from COVID-19

  In a retrospective study with 80 kidney transplant patients with COVID-19, treatment with tocilizumab demonstrates a decrease in one of the inflammat1

  Notícias
• July 24 2020

  Using social media to raise awareness about pneumonia

  Approximately 800,000 children and 1 million elderly people died of pneumonia around the world in 2017. Nevertheless, the severity of pneumonia is of1

  Notícias
• July 24 2020

  Effects of infection and confinement on Parkinson's disease during the COVID-19 pandemic

  COVID-19 affects people with Parkinson’s disease in a similar way to the general population, but it may be more serious in cases of advanced disease.1

  Notícias
• July 24 2020

  People who smoke and suffer from COPD are more vulnerable to COVID-19 complications

  Active smokers who have chronic obstructive pulmonary disease (COPD) are more likely to present serious forms of COVID-19. There are yet no studies c1

  Notícias
• September 2 2020

  Severe hypoglycaemia causes reduced cognitive function in elderly people with type 1 diabetes

  The low blood sugar (glucose) levels experienced by people with diabetes can affect the brain. A sudden drop in glucose causes neuronal death and, as1

  Notícias
• September 8 2020

  The Hospital Clínic and BSC will use Artificial Intelligence to predict the evolution of patients with COVID-19

  An AI model based on information from more than three thousand clinical reports generated by the Hospital Clínic during the acute phase of the pandem1

  Notícias